Medicinal Products


Name Tecartus
Active Substance autologous peripheral blood T cells CD4 and CD8 selected and CD3 and CD28 activated transduced with retroviral vector expressing anti-CD19 CD28/CD3-zeta chimeric antigen receptor and cultured
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
ATC Code L01X


The medicinal product has been authorised via centralised procedure in all Member States of the European Union based on the European Medicines Agency's expert opinion. Additional information on the medicinal product can be found under the following link:

The marketing authorisation has been granted by the European Commission. All marketing authorisations of the European Commission can be found under the following link: